Key result
PIP3 disrupts alpha-actinin bundling and enhances proteolysis while PIP2 inhibits bundling and decreases proteolysis.
Population
In vitro biochemical model studying alpha-actinin
Design
Preclinical
Authors
Loading...
No immediate clinical implications; hypothesis-generating for phosphoinositide control of alpha-actinin in cardiac cytoskeletal research.
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 differentially regulate alpha-actinin function by modulating its structure and flexibility.
Corgan et al. (2004) studied this question. Phosphoinositides (PtdIns(3,4,5)P3 and PtdIns(4,5)P2) was evaluated on alpha-actinin-bundling activity and proteolysis. PtdIns(3,4,5)P3 inhibits and disrupts alpha-actinin-bundling activity and enhances proteolysis, whereas PtdIns(4,5)P2 inhibits activity and decreases proteolysis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: